[Relationship between myocardial remodeling and neurohumoral activation in patients with cardiac failure]

Klinicheskaia Meditsina
|October 20, 2001
PubMed

Insights

Heart failure progression involves left ventricular shape changes and impaired diastolic function. Neurohumoral activation, particularly serotonin, hydrocortisone, and aldosterone, increases with worsening heart failure severity.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Medical Imaging

Context:

  • Heart failure (HF) affects millions globally, with coronary heart disease (CHD) being a primary cause.
  • Understanding the interplay between cardiac remodeling and neurohumoral activation is crucial for HF management.
  • Echocardiography and Doppler are key diagnostic tools for assessing cardiac function.

Purpose:

  • To investigate the relationship between left ventricular (LV) geometry changes and neurohumoral activation in heart failure patients.
  • To characterize the progression of cardiac failure using echocardiographic and plasma biomarker data.
  • To identify specific neurohormonal changes associated with different stages of heart failure.

Summary:

  • This study examined 50 healthy subjects and 685 CHD patients with heart failure (NYHA class I-IV).
  • Cardio-hemodynamics were assessed via M- and B-echocardiography, with transmitral Doppler used for analysis.
  • Plasma levels of epinephrine, norepinephrine, serotonin, aldosterone, STH, and hydrocortisone were measured.
  • Progression of heart failure is marked by LV remodeling from elliptical to spherical shape, increased cavity size, reduced relative wall thickness, heightened myocardial stress, and impaired diastolic function.
  • A strong correlation between myocardial remodeling and neurohumoral activation was observed, especially in asymptomatic heart failure.
  • With increasing LV dysfunction, serotonin, hydrocortisone, and aldosterone levels rose significantly compared to norepinephrine, epinephrine, and STH.

Impact:

  • Provides insights into the pathobiology of heart failure progression.
  • Highlights the role of specific neurohormones in cardiac remodeling and dysfunction.
  • May inform future therapeutic strategies targeting neurohumoral pathways in heart failure.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...